Combined Modality Therapy
"Combined Modality Therapy" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The treatment of a disease or condition by several different means simultaneously or sequentially. Chemoimmunotherapy, RADIOIMMUNOTHERAPY, chemoradiotherapy, cryochemotherapy, and SALVAGE THERAPY are seen most frequently, but their combinations with each other and surgery are also used.
Descriptor ID |
D003131
|
MeSH Number(s) |
E02.186
|
Concept/Terms |
Combined Modality Therapy- Combined Modality Therapy
- Multimodal Treatment
- Multimodal Treatments
- Treatment, Multimodal
- Treatments, Multimodal
- Therapy, Combined Modality
- Combined Modality Therapies
- Modality Therapies, Combined
- Modality Therapy, Combined
- Therapies, Combined Modality
|
Below are MeSH descriptors whose meaning is more general than "Combined Modality Therapy".
Below are MeSH descriptors whose meaning is more specific than "Combined Modality Therapy".
This graph shows the total number of publications written about "Combined Modality Therapy" by people in this website by year, and whether "Combined Modality Therapy" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1994 | 0 | 75 | 75 |
1995 | 0 | 77 | 77 |
1996 | 0 | 72 | 72 |
1997 | 0 | 70 | 70 |
1998 | 1 | 85 | 86 |
1999 | 0 | 90 | 90 |
2000 | 1 | 90 | 91 |
2001 | 2 | 99 | 101 |
2002 | 0 | 82 | 82 |
2003 | 1 | 156 | 157 |
2004 | 1 | 143 | 144 |
2005 | 0 | 149 | 149 |
2006 | 1 | 163 | 164 |
2007 | 2 | 161 | 163 |
2008 | 1 | 169 | 170 |
2009 | 2 | 159 | 161 |
2010 | 2 | 173 | 175 |
2011 | 4 | 142 | 146 |
2012 | 1 | 112 | 113 |
2013 | 7 | 131 | 138 |
2014 | 3 | 120 | 123 |
2015 | 3 | 136 | 139 |
2016 | 7 | 177 | 184 |
2017 | 6 | 157 | 163 |
2018 | 4 | 140 | 144 |
2019 | 8 | 146 | 154 |
2020 | 3 | 129 | 132 |
2021 | 2 | 73 | 75 |
2022 | 0 | 30 | 30 |
2023 | 0 | 40 | 40 |
2024 | 0 | 7 | 7 |
To return to the timeline,
click here.
Below are the most recent publications written about "Combined Modality Therapy" by people in Profiles.
-
Pembrolizumab versus placebo as adjuvant therapy in resected stage IIB or IIC melanoma: Outcomes in histopathologic subgroups from the randomized, double-blind, phase 3 KEYNOTE-716 trial. J Immunother Cancer. 2024 Mar 13; 12(3).
-
Expert consensus guidelines on management and best practices for tumor-infiltrating lymphocyte cell therapy. J Immunother Cancer. 2024 Feb 29; 12(2).
-
Reconciling the discrepancies in randomized data of combining immunotherapy and radiation therapy: Not all radiotherapy is created equal. Eur J Cancer. 2024 Apr; 201:113972.
-
Pan-cancer proteogenomics characterization of tumor immunity. Cell. 2024 Feb 29; 187(5):1255-1277.e27.
-
Response letter to "Stereotactic body radiation therapy for pleural mesothelioma: Which goal, which patients". Radiother Oncol. 2024 Apr; 193:110138.
-
The Next Chapter in Immunotherapy and Radiation Combination Therapy: Cancer-Specific Perspectives. Int J Radiat Oncol Biol Phys. 2024 Apr 01; 118(5):1404-1421.
-
Surgical Management and Considerations for Patients with Localized High-Risk Prostate Cancer. Curr Treat Options Oncol. 2024 Jan; 25(1):66-83.
-
Salvage Treatment of Recurrent or Persistent Anal Squamous Cell Carcinoma: The Role of Multi-modality Therapy. Clin Colorectal Cancer. 2024 Mar; 23(1):85-94.
-
Management of limited-stage Hodgkin lymphoma. Hematology Am Soc Hematol Educ Program. 2023 Dec 08; 2023(1):500-509.
-
Patient Navigation for Timely, Guideline-Adherent Adjuvant Therapy for Head and Neck Cancer: A National Landscape Analysis. J Natl Compr Canc Netw. 2023 12; 21(12):1251-1259.e5.